https://stoicscience.us/blog/ Short, practical notes on radiopharmaceutical QC, GxP documentation and the industry news that affects them. en-us https://stoicscience.us/blog/part-212-rewrite-missed-its-date.html https://stoicscience.us/blog/part-212-rewrite-missed-its-date.html Sun, 25 Oct 2026 12:00:00 +0000 Regulation The Food and Drug Administration's Part 212 rewrite was due as a proposed rule in 09/2026 and hasn't appeared. What it would change, and what labs can check.